---
$id: https://graph.org.ai/products/commodity/51241260
$type: Product
source: UNSPSC
code: "51241260"
title: "Tacalcitol monohydrate"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tacalcitol monohydrate

**UNSPSC Code**: 51241260
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vitamin d analog C27H44O3.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B3Q63NVN9R, chemically known as (+)-(5z,7e,24r)-9,10-secocholesta-5,7,10(19)-triene-1.alpha.,3.beta.,24-triol monohydrate, but more generally known as tacalcitol monohydrate, which bears US NIH Compound Identifier 9910819. European Medicines Agency schedules Tacalcitol monohydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22635. Most nations, for tariff and trade purposes, schedule tacalcitol monohydrate under HS 29061900 and SITC 51231. As of Q4 2014, TACALCITOL MONOHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@H](CC[C@H](C(C)C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C.O.

